Stay updated on Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial
Sign up to get notified when there's something new on the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page.

Latest updates to the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page
- Check4 days agoChange DetectedThe page revision label changed from v3.6.4 to v3.6.5, signaling a newer site build; no study record content or history entries were modified.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe record history now includes a new revision entry (v3.6.4), indicating an update to the study record after the previous version (v3.6.3). This reflects standard versioning of the record rather than a change to study details.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe record history now includes a new revision tag v3.6.3, updating the page's revision metadata and replacing the previous v3.6.2.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry v3.6.2 appears in the study history, replacing the previous v3.6.0 in the version list.SummaryDifference0.1%

- Check62 days agoChange DetectedThe latest version in the study record history indicates the recruitment status is not accepting participants, i.e., not currently recruiting, and is tagged as Revision: v3.6.0. The previous revision tag v3.5.5 has been removed.SummaryDifference0.3%

- Check69 days agoChange DetectedThe history now shows a new revision entry (v3.5.5) added to the history and the previous revision (v3.5.4) removed, updating the page's version history.SummaryDifference0.1%

Stay in the know with updates to Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page.